Home
Stempoint Capital reported a 9.9% stake in Faeth Therapeutics FTH · 132,873 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 9.9%
- Last report
- First report
- Shares held
- 132,873 sh
- Class
- Common Stock, $0.0001 par value per share
- Holder
- Stempoint Capital
- Event date
- 26/03/31
- Filed
- 26/05/15
First 5%+ report · 9.9% stake
Faeth Therapeutics trades, last 26 weeks
What else happened in Faeth Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Stempoint Capital's other 5% stake reports
- Stempoint Capital
5% stakeXilio Therapeutics
5% stakeXilio Therapeutics
XLO
9.5% stake
628,866 sh
9.5% stake
Filed 08/14
- Stempoint Capital
5% stakeSurrozen
5% stakeSurrozen
SRZN
5% stake
602,798 sh
5% stake
Filed 08/14
- Stempoint Capital
5% stakeFaeth Therapeutics
5% stakeFaeth Therapeutics
FTH
0% stake
0 sh
0% stake
Filed 08/14
- Stempoint Capital
5% stakeCellectar Biosciences
5% stakeCellectar Biosciences
CLRB
9.9% stake
845,740 sh
9.9% stake
Filed 08/14
- Stempoint Capital
5% stakeSurrozen
5% stakeSurrozen
SRZN
4.5% stake
525,639 sh
4.5% stake
Filed 05/15
